TY  - JOUR 
AU  - Pedrosa, M.A.
AU  - Labandeira Guerra, Carmen
AU  - Valenzuela Limiñana, Rita
AU  - Quijano, A.
AU  - Sanchez-Andrade, M.
AU  - Suárez Quintanilla, Juan Antonio
AU  - Lanciego, J.L.
AU  - Labandeira García, José Luis
AU  - Rodríguez Pérez, Ana Isabel
PY  - 2023
SN  - 1090-2139
UR  - http://hdl.handle.net/20.500.11940/21142
AB  - The metabolic syndrome has been associated to chronic peripheral inflammation and related with neuroinflammation and neurodegeneration, including Parkinson's disease. However, the responsible mechanisms are unclear. Previous studies have involved the...
LA  - eng
KW  - Animals
KW  - Humans
KW  - Rats
KW  - Angiotensin II
KW  - Angiotensin Receptor Antagonists
KW  - Angiotensin-Converting Enzyme 2
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Autoantibodies
KW  - Dopamine
KW  - Dopaminergic Neurons
KW  - Endothelial Cells
KW  - Inflammation
KW  - Metabolic Syndrome
KW  - Neuroinflammatory Diseases
KW  - Parkinson Disease
KW  - Receptor, Angiotensin, Type 1
TI  - AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
DO  - 10.1016/j.bbi.2022.12.009
T2  - Brain, Behavior, and Immunity
M2  - 255
KW  - AS Ourense
KW  - CHUO
KW  - AS Santiago
KW  - AS Santiago AP
KW  - AS Santiago
KW  - IDIS
KW  - AS A Coruña
KW  - AS Coruña AP
VL  - 108
ER  -